Apollo Endosurgery, Inc.
APEN · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $21 | $20 | $19 | $17 |
| % Growth | 8.9% | 1.4% | 15.9% | – |
| Cost of Goods Sold | $10 | $9 | $8 | $7 |
| Gross Profit | $11 | $11 | $11 | $9 |
| % Margin | 53.3% | 54.9% | 56.8% | 56.3% |
| R&D Expenses | $3 | $3 | $3 | $3 |
| G&A Expenses | $5 | $5 | $5 | $5 |
| SG&A Expenses | $15 | $14 | $14 | $13 |
| Sales & Mktg Exp. | $10 | $9 | $9 | $8 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19 | $17 | $18 | $17 |
| Operating Income | -$8 | -$6 | -$7 | -$7 |
| % Margin | -36.2% | -32.1% | -34.1% | -43.5% |
| Other Income/Exp. Net | -$2 | -$5 | -$4 | -$1 |
| Pre-Tax Income | -$9 | -$11 | -$10 | -$8 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10 | -$11 | -$10 | -$8 |
| % Margin | -44.8% | -58.5% | -54% | -50.5% |
| EPS | -0.32 | -0.28 | -0.26 | -0.21 |
| % Growth | -14.3% | -7.7% | -23.8% | – |
| EPS Diluted | -0.32 | -0.28 | -0.26 | -0.21 |
| Weighted Avg Shares Out | 30 | 41 | 40 | 40 |
| Weighted Avg Shares Out Dil | 30 | 41 | 40 | 40 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | -$3 | -$2 | $1 |
| EBITDA | -$5 | -$9 | -$8 | -$6 |
| % Margin | -21.4% | -47.8% | -43.7% | -37.6% |